​

Arvinas (ARVN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARVN Stock Forecast

Arvinas (ARVN) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $58.50, with a high of $69.00 and a low of $40.00. This represents a 233.33% increase from the last price of $17.55.

$15 $26 $37 $48 $59 $70 High: $69 Avg: $58.5 Low: $40 Last Closed Price: $17.55

ARVN Stock Rating

Arvinas stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (86.67%), 2 Hold (13.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 15 0 2 13 Strong Sell Sell Hold Buy Strong Buy

ARVN Forecast vs Benchmarks

TypeNameUpside
StockArvinas233.33%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts-37
Avg Price Target-$57.00$66.14
Last Closing Price$17.55$17.55$17.55
Upside/Downside-224.79%276.87%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 255152--22
Dec, 245152--22
Nov, 245142--21
Oct, 247132--22
Sep, 247132--22
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 10, 2024Jeet MukherjeeBTIG$69.00$24.59180.60%293.16%
Nov 19, 2024Christopher LiuLeerink Partners$62.00$24.94148.60%253.28%
Oct 31, 2024Matthew BieglerOppenheimer$40.00$27.6644.61%127.92%
Oct 21, 2024Bradley CaninoStifel Nicolaus$63.00$27.11132.39%258.97%
May 16, 2024Matthew BieglerOppenheimer$70.00$32.11118.00%298.86%
Apr 12, 2024Andrew FeinH.C. Wainwright$87.00$37.26133.49%395.73%
Apr 11, 2024Bradley CaninoStifel Nicolaus$72.00$38.7385.90%310.26%
Dec 19, 2023Derek ArchilaWells Fargo$63.00$37.8766.36%258.97%
Oct 23, 2023Robert DriscollWedbush$24.00$14.8361.83%36.75%
Jan 03, 2023Wells Fargo$49.00$34.2143.23%179.20%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Dec 10, 2024BTIGBuyinitialise
Nov 19, 2024Leerink PartnersOutperformOutperformhold
Oct 31, 2024OppenheimerOutperformOutperformhold
Sep 09, 2024WedbushBuyBuyhold
Jul 31, 2024Wells FargoBuyBuyhold
May 17, 2024Wells FargoBuyBuyhold
May 16, 2024OppenheimerOutperformOutperformhold
Apr 12, 2024H.C. WainwrightBuyBuyhold
Dec 19, 2023Wells FargoEqual-WeightOverweightupgrade
Dec 06, 2023JefferiesBuyupgrade

Financial Forecast

EPS Forecast

$-10 $-7 $-4 $-1 $2 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.83$-3.66$-5.11$-6.62-----
Avg Forecast$-2.76$-3.56$-4.94$-5.11$-3.15$-4.69$-4.51$-2.96$-1.22
High Forecast$-4.57$-5.89$-8.15$-5.68$-4.35$-8.05$-8.16$-7.26$-2.27
Low Forecast$-1.60$-2.06$-2.87$-4.56$-2.31$-2.93$0.94$2.52$-0.54
Surprise %2.54%2.81%3.44%29.55%-----

Revenue Forecast

$0 $190M $380M $570M $760M $950M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$21.80M$46.70M$131.40M$78.50M-----
Avg Forecast$26.24M$74.13M$120.80M$168.51M$264.73M$214.45M$252.55M$358.29M$548.04M
High Forecast$17.75M$50.15M$81.88M$152.61M$232.71M$123.45M$250.35M$353.32M$311.26M
Low Forecast$39.44M$111.40M$181.27M$197.30M$323.20M$341.08M$254.75M$363.26M$910.60M
Surprise %-16.92%-37.00%8.78%-53.42%-----

Net Income Forecast

$-500M $-370M $-240M $-110M $20M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-111.79M$-183.20M$-271.90M$-367.30M-----
Avg Forecast$-153.36M$-215.82M$-220.51M$-367.30M$-184.72M$-341.42M$-363.59M$-282.85M$-67.88M
High Forecast$-253.61M$-258.98M$-264.61M$-440.76M$-241.41M$-446.89M$-452.74M$-402.83M$-126.25M
Low Forecast$-88.87M$-172.65M$-176.41M$-293.84M$-128.03M$-162.87M$51.90M$139.59M$-29.75M
Surprise %-27.11%-15.11%23.31%------

ARVN Forecast FAQ

Is Arvinas stock a buy?

Arvinas stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Arvinas is a favorable investment for most analysts.

What is Arvinas's price target?

Arvinas's price target, set by 15 Wall Street analysts, averages $58.5 over the next 12 months. The price target range spans from $40 at the low end to $69 at the high end, suggesting a potential 233.33% change from the previous close price of $17.55.

How does Arvinas stock forecast compare to the average forecast of its sector, industry, and investment themes?

Arvinas stock forecast shows a 233.33% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Arvinas over the past three months?

  • January 2025: 22.73% Strong Buy, 68.18% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 22.73% Strong Buy, 68.18% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 23.81% Strong Buy, 66.67% Buy, 9.52% Hold, 0% Sell, 0% Strong Sell.

What is Arvinas’s EPS forecast?

Arvinas's average annual EPS forecast for its fiscal year ending in December is -3.15 for 2024, a -52.42% decrease from the reported $-6.62 in 2023. The prediction for 2025 is $-4.69, $-4.51 for 2026, $-2.96 for 2027, and $-1.22 for 2028.

What is Arvinas’s revenue forecast?

Arvinas's average annual revenue forecast for its fiscal year ending in December is $264.73M for 2024, a 237.23% increase from the reported $78.5M in 2023. The forecast for 2025 is $214.45M, $252.55M for 2026, $358.29M for 2027, and $548.04M for 2028.

What is Arvinas’s net income forecast?

For its fiscal year ending in December, Arvinas's average annual net income forecast is $-185M for 2024, reflecting a -49.71% decrease from the reported $-367M in 2023. The projection for 2025 is $-341M, $-364M for 2026, $-283M for 2027, and $-67.877M for 2028.